new approach for emphysema treatment

Uptake Medical, which is developing new medical device technologies to treat emphysema, has raised $35 million of a $41 million venture capital round, according to a SEC filing.

see a video on new approach works and if it's for you

Here’s a closer look at how Uptake’s InterVapor technology works, which utilizes heated water vapor to reduce diseased tissue in emphysema patients.

new procedure InterVapor used to treat severe emphysema

Surgical and endoscopic options can be considered in patients with severe emphysema once they have been treated with many of the above treatment options, but still remain disabled due to the disease. These options include:

• Surgical Options: Lung volume reduction surgery removes a portion of the diseased lung tissue and has been shown to improve lung function, symptoms and exercise capacity. Lung transplantation is an option for only a very select groups of patients. Even though both are effective, they are associated with significant risks and complications for the few patients who qualify for them, and are rarely used.

• Endoscopic Lung Volume Reduction (ELVR): A relatively new group of non-surgical treatments use a bronchoscope – a small flexible tube with a light and camera lens – to permanently treat and reduce hyperinflation. These include placing one-way valves, wire-like coils or chemical foam sealant into the lungs. All of these ELVR treatments are designed to provide a permanent approach to treating hyperinflation. InterVapor™ is also in this group. But unlike these other treatments, InterVapor uses only heated water vapor and the body’s healing process to effectively reduce the size and volume of the lung.

read more on this new procedure for emphysema